Literature DB >> 30177790

Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis.

Dietmar M W Zaiss1, Paul J Coffer2,3.   

Abstract

Lymphocytes have evolved to react rapidly and robustly to changes in their local environment by using transient adaptations and by regulating their terminal differentiation programmes. Forkhead box transcription factors (FTFs) can direct leukocyte-specific responses, and their functional diversification promotes a high degree of context-dependent specification. Many, often antagonistic, FTFs have overlapping expression patterns and can thereby compete for binding to the same chromosomal target sequences. Multiple molecular mechanisms also connect extracellular signals to the expression and functionality of specific FTFs and, in this way, fine-tune their activity. Through these diverse mechanisms, FTFs can function as context-dependent rheostats responding to diverse environmental stimuli. Focusing on the various mechanisms by which their functional activity is modulated, as well as on their mechanisms of action, we discuss how specific FTFs control lymphocyte function, allowing for the establishment and maintenance of immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30177790     DOI: 10.1038/s41577-018-0048-9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  120 in total

Review 1.  Forkhead-box transcription factors and their role in the immune system.

Authors:  Paul J Coffer; Boudewijn M T Burgering
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

2.  Regulatory T cell development in the absence of functional Foxp3.

Authors:  Wen Lin; Dipica Haribhai; Lance M Relland; Nga Truong; Marc R Carlson; Calvin B Williams; Talal A Chatila
Journal:  Nat Immunol       Date:  2007-02-02       Impact factor: 25.606

Review 3.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

Review 4.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

5.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

6.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

Review 7.  Forkhead transcription factors: key players in health and disease.

Authors:  Bérénice A Benayoun; Sandrine Caburet; Reiner A Veitia
Journal:  Trends Genet       Date:  2011-04-18       Impact factor: 11.639

Review 8.  The cunning little vixen: Foxo and the cycle of life and death.

Authors:  Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

Review 9.  FOXO transcription factors throughout T cell biology.

Authors:  Stephen M Hedrick; Rodrigo Hess Michelini; Andrew L Doedens; Ananda W Goldrath; Erica L Stone
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

10.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  8 in total

Review 1.  B-cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells.

Authors:  Roberta Pelanda; Sarah A Greaves; Thiago Alves da Costa; Lena M Cedrone; Margaret L Campbell; Raul M Torres
Journal:  Immunol Rev       Date:  2022-01-08       Impact factor: 12.988

2.  PI3K Isoforms in B Cells.

Authors:  Elissa K Deenick; Julia Bier; Anthony Lau
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

3.  Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis.

Authors:  Qingyang Meng; Xiangjun Wang; Tongqing Xue; Qiangfang Zhao; Wei Wang; Kun Zhao
Journal:  Cancer Cell Int       Date:  2020-08-27       Impact factor: 5.722

4.  Integrated analysis of immune-related genes in endometrial carcinoma.

Authors:  Yiru Wang; Yunduo Liu; Yue Guan; Hao Li; Yuan Liu; Mengjun Zhang; Ping Cui; Dan Kong; Xiuwei Chen; Hang Yin
Journal:  Cancer Cell Int       Date:  2020-10-02       Impact factor: 5.722

Review 5.  The Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus.

Authors:  Yueqi Qiu; Xingyu Zhou; Yu Liu; Siqi Tan; Yaping Li
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 6.  Transcriptional regulation of Treg homeostasis and functional specification.

Authors:  Ke Wang; Wenxian Fu
Journal:  Cell Mol Life Sci       Date:  2020-04-29       Impact factor: 9.207

7.  FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma.

Authors:  Jinzhang Chen; Xiaoxiang Rong; Xinhui Liu; Dayong Zheng; Xiaodong Rong; Fengsheng Chen; Peng Zhao; Feiye Liu; Jian Ruan
Journal:  Cancer Cell Int       Date:  2020-05-26       Impact factor: 5.722

8.  MAP4K3/GLK inhibits Treg differentiation by direct phosphorylating IKKβ and inducing IKKβ-mediated FoxO1 nuclear export and Foxp3 downregulation.

Authors:  Jyun-Ni Chi; Jhih-Yu Yang; Chia-Hsin Hsueh; Ching-Yi Tsai; Huai-Chia Chuang; Tse-Hua Tan
Journal:  Theranostics       Date:  2022-07-18       Impact factor: 11.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.